American Journal of Ophthalmology
Volume 149, Issue 5 , Pages 807-816 , May 2010

Association Between Abnormal Contrast Sensitivity and Mortality Among People With Acquired Immunodeficiency Syndrome

  • Gary N. Holland

      Affiliations

    • Ocular Inflammatory Disease Center, Jules Stein Eye Institute and the Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California
    • Corresponding Author InformationInquiries to Gary N. Holland, Jules Stein Eye Institute, 100 Stein Plaza, UCLA, Los Angeles, CA 90095-7003
    • ,
  • Peter J. Kappel

      Affiliations

    • Ocular Inflammatory Disease Center, Jules Stein Eye Institute and the Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California
    • ,
  • Mark L. Van Natta

      Affiliations

    • Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland
    • ,
  • Frank J. Palella

      Affiliations

    • Department of Medicine, Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois
    • ,
  • Alice T. Lyon

      Affiliations

    • Retina Study Center, Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
    • ,
  • Kayur H. Shah

      Affiliations

    • Ocular Inflammatory Disease Center, Jules Stein Eye Institute and the Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California
    • ,
  • Peter R. Pavan

      Affiliations

    • Department of Ophthalmology, University of South Florida College of Medicine, Tampa, Florida
    • ,
  • Douglas A. Jabs

      Affiliations

    • Department of Ophthalmology, Mount Sinai School of Medicine, New York, New York
    • ,
  • Studies of the Ocular Complications of AIDS Research Group

,Accepted 15 December 2009.

References 

  1. Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD. Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment. Ophthalmology. 2007;114:780–786
  2. Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD. Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment. Ophthalmology. 2007;114:787–793
  3. Shah KH, Holland GN, Yu F, Van Natta M, Nusinowitz S. Contrast sensitivity and color vision in HIV-infected individuals without infectious retinopathy. Am J Ophthalmol. 2006;142:284–292
  4. Freeman WR, Van Natta ML, Jabs D, et al. Vision function in HIV-infected individuals without retinitis: report of the Studies of Ocular Complications of AIDS Research Group. Am J Ophthalmol. 2008;145:453–462
  5. Arend O, Remky A, Evans D, Stuber R, Harris A. Contrast sensitivity loss is coupled with capillary dropout in patients with diabetes. Invest Ophthalmol Vis Sci. 1997;38:1819–1824
  6. Harris A, Arend O, Danis RP, Evans D, Wolf S, Martin BJ. Hyperoxia improves contrast sensitivity in early diabetic retinopathy. Br J Ophthalmol. 1996;80:209–213
  7. Grauslund J, Green A, Sjolie AK. Proliferative retinopathy and proteinuria predict mortality rate in type 1 diabetic patients from Fyn County, Denmark. Diabetologia. 2008;51:583–588
  8. Juutilainen A, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women. Diabetes Care. 2007;30:292–299
  9. van Hecke MV, Dekker JM, Stehouwer CD, et al. Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study. Diabetes Care. 2005;28:1383–1389
  10. Klein R, Klein BE, Moss SE, Cruickshanks KJ. Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol. 1999;117:1487–1495
  11. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121:293–298
  12. Elliott D, Billimore MA, Bailey IL. Improving the reliability of the Pelli-Robson contrast sensitivity test. Clinical Vision Sciences. 1991;6:471–475
  13. Lovie-Kitchin JE, Brown B. Repeatability and intercorrelations of standard vision tests as a function of age. Optom Vis Sci. 2000;77:412–420
  14. Myers VS, Gidlewski N, Quinn GE, Miller D, Dobson V. Distance and near visual acuity, contrast sensitivity, and visual fields of 10-year-old children. Arch Ophthalmol. 1999;117:94–99
  15. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–470
  16. Altman DG. Practical statistics for medical research. In: London: Chapman and Hall; 1993;p. 241–248
  17. Tarwater PM, Mellors J, Gore ME, et al. Methods to assess population effectiveness of therapies in human immunodeficiency virus incident and prevalent cohorts. Am J Epidemiol. 2001;154:675–681
  18. Holland GN. AIDS and ophthalmology: the first quarter century. Am J Ophthalmol. 2008;145:397–408
  19. Rubin GS, Roche KB, Prasada-Rao P, Fried LP. Visual impairment and disability in older adults. Optom Vis Sci. 1994;71:750–760
  20. Ivers RQ, Cumming RG, Mitchell P, Attebo K. Visual impairment and falls in older adults: the Blue Mountains Eye Study. J Am Geriatr Soc. 1998;46:58–64
  21. Lord SR, Clark RD, Webster IW. Visual acuity and contrast sensitivity in relation to falls in an elderly population. Age Ageing. 1991;20:175–181
  22. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women (Study of Osteoporotic Fractures Research Group). N Engl J Med. 1995;332:767–773
  23. Dargent-Molina P, Favier F, Grandjean H, et al. Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet. 1996;348:145–149
  24. Braithwaite RS, Col NF, Wong JB. Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc. 2003;51:364–370
  25. Kanis JA, Oden A, Johnell O, De Laet C, Jonsson B, Oglesby AK. The components of excess mortality after hip fracture. Bone. 2003;32:468–473
  26. Ball K, Owsley C, Sloane ME, Roenker DL, Bruni JR. Visual attention problems as a predictor of vehicle crashes in older drivers. Invest Ophthalmol Vis Sci. 1993;34:3110–3123
  27. Owsley C, Stalvey BT, Wells J, Sloane ME, McGwin G. Visual risk factors for crash involvement in older drivers with cataract. Arch Ophthalmol. 2001;119:881–887
  28. Pedula KL, Coleman AL, Hillier TA, et al. Visual acuity, contrast sensitivity, and mortality in older women: Study of osteoporotic fractures. J Am Geriatr Soc. 2006;54:1871–1877
  29. Gimeno Orna JA, Castro Alonso FJ, Sanchez Vano R, Latre Rebled B, Lou Arnal LM, Molinero Herguedas E. Diabetic retinopathy and mortality in type 2 diabetic patients. Med Clin (Barc). 2006;126:686–689
  30. Targher G, Bertolini L, Zenari L, et al. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients. Diabet Med. 2008;25:45–50
  31. Geier SA, Hammel G, Bogner JR, Kronawitter U, Berninger T, Goebel FD. HIV-related ocular microangiopathic syndrome and color contrast sensitivity. Invest Ophthalmol Vis Sci. 1994;35:3011–3021
  32. Pepose JS, Holland GN, Nestor MS, Cochran AJ, Foos RY. Acquired immune deficiency syndrome (Pathogenic mechanisms of ocular disease). Ophthalmology. 1985;92:472–484
  33. Knudtson MD, Klein BE, Klein R. Age-related eye disease, visual impairment, and survival: the Beaver Dam Eye Study. Arch Ophthalmol. 2006;124:243–249
  34. Taylor HR, McCarty CA, Nanjan MB. Vision impairment predicts five-year mortality. Trans Am Ophthalmol Soc. 2000;98:91–96discussion 96–99

PII: S0002-9394(09)00960-X

doi: 10.1016/j.ajo.2009.12.019

American Journal of Ophthalmology
Volume 149, Issue 5 , Pages 807-816 , May 2010

Article Tools

* Image Usage & Resolution